Ovaterra

What Ovaterra does

Ovaterra, operated under parent entity Fertility Nutraceuticals and headquartered in New York, is a clinical-grade fertility and reproductive health supplement company selling direct-to-consumer via myovaterra.com. Its portfolio spans DHEA (Fertinatal®), CoQ10 for women and men (OvoEnergen™ and AndroEnergen™), an advanced prenatal with choline and methylated folate, an anti-inflammatory supplement (Ovamune™), a female sexual-health product (Vivo®), and Vitamin D3+K2, together with age-segmented bundle packs for women 34 & Under, 35–39, and 40+. The company's core technical differentiators are the patented VESIsorb® absorption technology licensed from Vesifact AG (ETH Zurich) for its CoQ10 SKUs (claiming up to 6x bioavailability vs. standard ubiquinol), patented micronized DHEA matched to particle sizes used in clinical studies, and triple-tested third-party lab verification on every batch. The IP portfolio comprises 10 US and Canadian patents covering formulations and technology, including co-inventor positions on US patents for the use of DHEA in fertility held by Dr. Norbert Gleicher and Dr. David Barad of the Center for Human Reproduction (CHR).

Name

Ovaterra

Legal name

Ovaterra

Website

https://myovaterra.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

Ovaterra is a New York-based clinical-grade fertility supplement company selling direct-to-consumer patented DHEA, CoQ10, prenatal, anti-inflammatory, and sexual health products for couples trying to conceive.

Ownership category

akta.pro rank

Product category

Fertility Supplements

NAICS

Food (Health) Supplement Retailers (456191), Health and Personal Care Retailers (456)

akta.pro industry

PRIMARYCRADAGAK

Women’s Health Supplements (Prenatal, Menopause, Hormonal)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

SECONDARYCRABAIAK

Fertility & Ovulation Products (OTC)

Consumer Products & Retail/Beauty & Personal Care/Feminine Care

SECONDARYHLAIAAAJ

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYCRADAEAJ

Prenatal & Postnatal Maternal Nutrition (Lactation Support)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Infant & Baby Food & Nutrition

SECONDARYCRADAGAE

Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

Keywords

• Fertility supplements
• Reproductive health products
• Prenatal vitamins
• Fertility nutraceuticals
• Preconception supplements

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Marketing or Sales, Technology or R&D, Personnel, Supply Chain

Revenue model

1. Direct E-commerce Sales: Primary revenue stream through direct-to-consumer sales via myovaterra.com. Products sold as one-time purchases or subscription orders with 10-12% savings for subscribers. Includes free standard US shipping on orders over $100.
2. Subscription (Subscribe & Save): Recurring subscription model offering 10-12% discount on all products. Subscribers receive automatic refills and exclusive benefits. Powered by Recharge Payments platform.
3. Wholesale/B2B: Wholesale application available for retailers and distributors interested in carrying Ovaterra products.
4. Marketplace Sales (Amazon): Vivo sexual health supplement available for purchase on Amazon, providing additional distribution channel beyond owned e-commerce.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Ovaterra sells clinical-grade fertility and reproductive health supplements directly to consumers through its e-commerce site myovaterra.com. The product portfolio spans standalone supplements (Ovamune anti-inflammatory, Vivo sexual health, Fertinatal DHEA, OvoEnergen CoQ10, AndroEnergen CoQ10, Advanced Prenatal, Vitamin D3+K2) and age-specific preconception bundles for women 34 & under, 35-39, and 40+. Products are developed in collaboration with the Center for Human Reproduction in New York and backed by 10 US/Canadian patents, including patented VESIsorb absorption technology for CoQ10.

Product overview

Ovaterra (by Fertility Nutraceuticals) is a science-backed fertility and reproductive health supplement company offering clinical-grade nutritional supplements for women and men. The product portfolio includes standalone supplements (Ovamune™ anti-inflammatory, Vivo® sexual health, Fertinatal® DHEA, OvoEnergen™ CoQ10, AndroEnergen™ CoQ10, Advanced Prenatal, Vitamin D3+K2) and age-specific bundle packs (Preconception Packs for Women 40+, 35-39, and 34 & Under; His & Hers Fertility Bundle; Egg Health Power Pack). Products are developed in collaboration with the Center for Human Reproduction (CHR) in New York City and are backed by 10 US and Canadian patents. The company holds 10 patents for formulations and technology, uses VESIsorb® absorption technology for CoQ10 products, and implements triple-tested quality assurance with independent laboratory testing.

Differentiator

Problem solved

Functional benefit

Brands

• Ovamune™: Anti-inflammatory supplements for women developed in collaboration with fertility experts to support reproductive health by modulating inflammation and reducing cellular oxidative stress.
• Vivo®
• Fertinatal®
• OvoEnergen™
• AndroEnergen™

Products and services

• Ovamune Anti-Inflammatory Supplements Anti-inflammatory and antioxidant supplement designed to support female reproductive health by modulating inflammation and reducing cellular oxidative stress. Targeted at women trying to conceive who experience inflammation-related fertility challenges.
• Vivo Sexual Health Supplement for Women Sexual health supplement containing DHEA (dehydroepiandrosterone), a hormone precursor supporting healthy testosterone levels for female sexual desire, arousal, and satisfaction. Targeted at premenopausal women seeking clinically studied sexual wellness support.
• Fertinatal DHEA for Women Patented micronized DHEA supplement designed to support ovarian health, developed in partnership with the Center for Human Reproduction. Contains 25mg DHEA per capsule from wild yam.
• Advanced Prenatal Vitamins with Choline Prenatal vitamins with 24 essential vitamins and minerals in bioavailable forms; the only prenatal vitamin capsule containing the full recommended daily value of brain-building choline (550mg), plus methylated folate (Quatrefolic).
• OvoEnergen Ubiquinol CoQ10 for Women CoQ10 supplement in active ubiquinol form with patented VESIsorb absorption technology for enhanced bioavailability; 100mg softgels designed to support egg health and female reproductive health. Co-developed with Dr. David Barad and Vesifact AG.
• Advanced Preconception Vitamins for Women 35-39 Age-specific preconception vitamins for women 35-39, containing 24 prenatal vitamins and minerals with 25mg patented micronized DHEA and 550mg choline; only preconception vitamin with full recommended daily value of choline.
• Vitamin D3 with K2 Liquid vitamin supplement combining Vitamin D3 (1,000 IU/drop) with Vitamin K2 (100mcg) in organic olive oil base. Developed with Dr. Bruce Hollis at Medical University of South Carolina.
• AndroEnergen Ubiquinol CoQ10 for Men Male fertility supplement containing 100mg clinical-grade CoQ10 in active ubiquinol form with VESIsorb technology, designed to support sperm health. Co-developed with Dr. David Barad and Vesifact AG.

Quantifiable outcome

• VESIsorb® technology delivers up to six times better CoQ10 absorption compared to standard ubiquinone formulations
• +2 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered flagship, core and minor.

• Center for Human Reproduction (CHR)flagshipStrategic or Co-development PartnerCenter for Human Reproduction is a leading fertility clinic in New York City and Ovaterra's primary research collaborator. Products are developed in collaboration with CHR researchers, including Dr. Norbert Gleicher and Dr. David Barad who are co-inventors on DHEA patents. CHR led the early research into DHEA and female reproductive health. Fertinatal® DHEA was developed in partnership with CHR.
• Vesifact AG (Federal Institute of Technology Zurich)coreTechnology or IntegrationScientists from the Federal Institute of Technology in Zurich developed the VESIsorb® absorption technology. Ovaterra co-developed OvoEnergen™ and AndroEnergen™ CoQ10 products in collaboration with these scientists. VESIsorb® transforms fat-soluble CoQ10 into water-compatible colloidal droplets.
• Dr. Norbert GleichercoreStrategic or Co-development PartnerMD, FACOG, FACS - Co-Inventor in US Patents for the use of DHEA in Fertility. Medical Director at Center for Human Reproduction. Products based on his research include Fertinatal DHEA. Leading researcher in reproductive endocrinology and infertility.
• Dr. David BaradcoreStrategic or Co-development PartnerMD, MS, FACOG - Leading fertility researcher and co-inventor on DHEA patents. Co-developed CoQ10 products (OvoEnergen™ and AndroEnergen™) with Ovaterra. Clinical expertise in reproductive health.
• Dr. Bruce HolliscoreStrategic or Co-development PartnerPh.D. from Medical University of South Carolina, Director of Pediatric Nutritional Science. Developed Vitamin D3 with K2 supplement in partnership with Ovaterra. Research focuses on vitamin D and reproductive health.
• Rebecca FettcoreStrategic or Co-development PartnerAuthor of best-selling book 'It Starts with the Egg.' Co-developed Advanced Prenatal vitamins with Ovaterra. Expert in fertility nutrition and egg quality supplementation.
• EvewellminorStrategic or Co-development PartnerFertility clinic in London, UK listed as a recommended fertility clinic that Ovaterra products are associated with. One of several clinic partnerships globally.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Care/of: Personalized vitamin and supplement DTC brand with quiz-based recommendations. Overlaps in DTC supplement category, subscription model, and wellness-focused female demographic, though broader than fertility-only.
• Garden of Life: Major prenatal and women's health supplement brand (Nestlé Health Science subsidiary). Competes in the prenatal category with broader mass-market distribution including retail and practitioner channels.
• Nordic Naturals: Omega-3 and prenatal supplement brand with overlapping prenatal products (DHA, vitamin D3). Comparable in evidence-based positioning and use of bioavailable nutrient forms for reproductive and pregnancy health.

Direct peers

• Needed: DTC fertility, pregnancy, and postpartum nutrition brand with subscription model. Directly comparable in product mix (prenatals, fertility support), target customer (women trying to conceive and through postpartum), and clinician-backed formulation approach.
• Perelel: OB/GYN-founded prenatal vitamin brand with stage-specific formulations (conception, prenatal, postnatal) and subscription DTC model. Directly comparable in clinical credibility positioning and reproductive life-stage targeting.
• Theralogix: Direct competitor in clinical-grade fertility supplements, majority-owned by Nestlé Health Science. Operates in the same DTC channel targeting women trying to conceive, with overlapping product categories including prenatal vitamins and fertility-specific formulations.
• Fairhaven Health: Established fertility supplement brand offering products for both women and men, including fertility blends, prenatal vitamins, and male reproductive health support. Directly comparable product portfolio and customer base.
• Ritual: DTC supplement brand with a clinically-backed Essential Prenatal among its products, similar subscription model, and comparable target demographic of health-conscious women including those in preconception stages.

Emerging players

• Persona Nutrition: Personalized nutrition supplement brand offering fertility and prenatal formulations through subscription. Comparable in DTC subscription model and personalized supplement approach targeting women's reproductive health.
• Premama: Fertility and prenatal nutrition brand offering products for conception and pregnancy support, including fertility drinks and supplements. Comparable in target customer and life-stage focus, though smaller in scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ovaterra